Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse

By Weizman Abraham   Weizman Ronit  

Pharmacogenomics, Vol. 1, Iss. 3, 2000-08 ,pp. : 335-341

Future Medicine

Access to resources Recommend Favorite

Antiepileptic Drugs in the Treatment of Anxiety Disorders: Role in Therapy

By Michael Van Ameringen   Catherine Mancini   Beth Pipe   Mark Bennett  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2199-2220

Adis International

Access to resources Recommend Favorite

Role of Pharmacogenomics in Individualising Treatment with SSRIs

By Mancama D.   Kerwin R.W.  

CNS Drugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 143-151

Adis International

Access to resources Recommend Favorite

Risk of congenital disorders with maternal use of SSRIs

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Pharmacological Profile of SSRIs and SNRIs in the Treatment of Eating Disorders

By  

Current Clinical Pharmacology, Vol. 4, Iss. 1, 2009-01 ,pp. : 78-83

Bentham Science Publishers

Access to resources Recommend Favorite